Science at Sanofi

This educational video examines the prevalence of moderate and severe atopic dermatitis in children, presenting data that describes the significant disease burden and its impact on both pediatric patients and their families. The content explores current challenges in achieving optimal disease control in children with moderate and severe atopic dermatitis, providing healthcare professionals with evidence-based insights into the clinical management complexities of this patient population.

The soundbite recording captures Dr. Paller's discussion on factors that contribute to the development of atopic comorbidities in patients with atopic dermatitis. The presentation examines the relationship between AD and associated atopic conditions.

This educational video features Dr. Eric Simpson's presentation on the Impact of Advanced Systemic Therapies on Disease Control in AD

This approximately 3-minute clip focuses on the potential role of early therapeutic intervention in influencing the disease course of atopic dermatitis in children. The segment explores whether timely treatment approaches can modify disease trajectory in pediatric populations.

The soundbite recording captures Dr. Paller's discussion examining whether early therapeutic intervention can influence the natural course of atopic dermatitis. The presentation explores the potential for timely treatment approaches to modify disease trajectory.

The soundbite recording captures Dr. Paller's presentation examining the relationship between age of disease onset and AD persistence. The discussion explores how earlier onset of atopic dermatitis may influence disease trajectory and long-term outcomes in patients.

The soundbite recording captures Dr. Ramien's discussion of disease modification concepts in atopic dermatitis, exploring current understanding and approaches to altering disease progression.

The soundbite recording captures Dr. Simpson's discussion exploring the concept of remission in atopic dermatitis, examining what remission could mean in the context of AD management and patient outcomes.

Watch Professor Mohamed Hassanein, consultant endocrinologist in Dubai Hospital, Dubai Health Authority and the chair of Diabetes and Ramadan International Alliance shedding the light on what are the unmet needs amongst Muslims with Type 2 diabetes when fast during Ramadan.

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Dr. Salah gives us the updated guidelines on Sulphonylureas and Cardiovascular safety

Prof. Joseph A. Caprini provides insights on VTE Risk in Hospital and beyond by supporting the initiative on  preventing the number one preventable cause of death after surgery: fetal pulmonary embolism

Dr. Hussein Elbadawi talks about Hypoglycemia and how is it classified.

Dr. Kalra discusses Quinary Prevention in Diabetes Care

Dr. Nabil talks about Sulphonylureas within treatment landscape in Ramadan

Dr. Khudhair discusses Carolina: Cardiovascular outcomes